ClinicalTrials.Veeva

Menu
N

New Life Medical Research Center, Inc. | Hialeah, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

AVP-786
ACP-204
Aticaprant
Paliperidone Palmitate
Piromelatine
Quetiapine XR
JNJ-53718678
Buntanetap
Vafidemstat
Seltorexant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 18 total trials

A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy (VENTURA-1)

The purpose of this study is to evaluate the efficacy of aticaprant compared with placebo as adjunctive therapy to an antidepressant in improving dep...

Enrolling
Depressive Disorder, Major
Anhedonia
Drug: Aticaprant
Other: Placebo

The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepres...

Enrolling
Depressive Disorder, Major
Drug: Aticaprant
Locations recently updated

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with mod...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: KarXT

This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...

Enrolling
Alzheimer's Disease Psychosis
Drug: Placebo
Drug: ACP-204
Locations recently updated

This 52-week, open-label extension study is to evaluate the long-term safety and tolerability of ACP-204 in subjects with ADP.

Invitation-only
Alzheimer's Disease Psychosis
Drug: ACP-204

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...

Active, not recruiting
Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786

The purpose of this phase 2 multicenter, randomized, double-blind, placebo-controlled, study is to assess the safety and efficacy of ifetroban in pat...

Enrolling
Scleroderma, Limited
Scleroderma, Systemic
Drug: Oral Ifetroban
Drug: Oral Placebo

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Otsuka logo
Acadia Pharmaceuticals logo
A
Biogen logo
Cumberland Pharmaceuticals logo
Karuna Therapeutics logo
Lilly logo
N
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems